Home539871 • BOM
add
Thyrocare Technologies Ltd
Previous close
₹620.80
Day range
₹611.10 - ₹626.15
Year range
₹449.95 - ₹722.00
Market cap
32.81B INR
Avg Volume
4.35K
P/E ratio
50.65
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 1.35B | 5.24% |
Operating expense | 518.40M | 22.21% |
Net income | 153.50M | 4.28% |
Net profit margin | 11.39 | -0.96% |
Earnings per share | — | — |
EBITDA | 259.65M | 4.86% |
Effective tax rate | 25.97% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 993.40M | -17.30% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 4.88B | — |
Shares outstanding | 55.22M | — |
Price to book | 6.76 | — |
Return on assets | — | — |
Return on capital | 8.47% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 153.50M | 4.28% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai, Maharashtra. The company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,645
